Sponsors (66)
The bill aims to improve overdose care by producing federal guidance on routine fentanyl testing (helping clinicians and hospitals) but risks increased testing costs for providers and privacy/data-security and trust concerns for patients unless safeguards and funding are put in place.
Emergency department patients with suspected overdose (and the clinicians treating them) would get clearer federal guidance on when to perform routine fentanyl testing, likely improving clinical decision-making and patient outcomes in overdose care.
Clinicians will have clearer information on which substances routine tests detect, improving diagnostic accuracy and appropriate treatment for overdose patients.
Hospitals and health-system administrators would receive guidance on testing frequency and costs, helping them allocate resources and plan budgets more efficiently.
Patients (and their relationship with clinicians) and hospitals face added privacy and trust risks: guidance could lead to more frequent testing and the study may require sharing sensitive patient data, increasing potential data-security and confidentiality harms if protections are insufficient.
If guidance effectively recommends more routine fentanyl testing, hospitals—especially smaller or rural facilities—could face meaningful new costs to implement testing, straining budgets and possibly limiting other services.
Conducting the mandated study and issuing guidance will use HHS resources and incur administrative costs borne by taxpayers.
Based on analysis of 2 sections of legislative text.
Requires HHS to study ED fentanyl testing for overdose patients within 1 year and issue guidance within 6 months after the study on testing practices and impacts.
Requires the HHS Secretary to study how hospital emergency departments currently test overdose patients for fentanyl and related impacts, and then issue guidance based on the study. The study must be completed within one year and the guidance issued within six months afterward, covering testing frequency, costs, patient benefits and risks, privacy and patient–physician relationship issues, clinician awareness of test coverage, and effects on future overdose risk and health outcomes.
Official title: Tyler’s Law
Introduced March 10, 2025 by Ted Lieu · Last progress September 16, 2026